<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2008-09-17 18:31:32Pharmaceutical sciences Off-label use Food and Drug Administration Package insert Prescription medication Investigational New Drug Pharmaceutical industry Adverse effect Moxifloxacin Medicine Pharmacology Health |
Add to Reading List |
Off-Label: Just What the Doctor Ordered | Morphochem’s Investigational New Drug (IND) application accepted by FDA – Novel antibacterial for IV treatment of CDI ready to move to Phase 2 Munich (Germany), June 22, 2016 — Morphochem, a clinical-stage pharmaceDocID: 1uvYN - View Document |
| Guidance for Industry Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic,DocID: 1sDEk - View Document |
| Emergency Use: means the use of a test article on a human subject in a life-threatening situation inDocID: 1riMu - View Document |
| Microsoft Word - 7494fnl.docDocID: 1qYy2 - View Document |
| Microsoft WorddocDocID: 1qVAJ - View Document |